Not Yet RecruitingPhase 2ACTRN12609001043224

Management of Refeeding Syndrome in Critical Illness: An Australasian Society of Parenteral and Enteral Nutrition (AuSPEN) Endorsed Multi-centre Phase II Randomised Controlled Trial.

In Critically Ill patients with Refeeding-related Hypophosphataemia, does energy restricted nutritional support compared with Standard/Usual care affect Intensive Care Unit (ICU) free days. A Phase II multi-centre randomised controlled trial.

Sponsor

National Health and Medical Research Council (NHMRC)

Enrollment

348 participants

Start Date

Jan 1, 2010

Study Type

Interventional

Conditions

Nutrition - Refeeding-related Hypophosphatemia

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study looks at how to best manage refeeding syndrome in critically ill patients in the ICU. Refeeding syndrome can happen when nutrition is restarted after a period of not eating, causing dangerous drops in phosphate levels. The study compares different approaches to continuing nutritional support in adults aged 18 and older who develop low phosphate levels within 72 hours of starting feeding in the ICU.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Protocol directed and energy restricted nutritional support during management of refeeding-related hypophosphataemia. Protocol currently under development by management committee and will be based on

Protocol directed and energy restricted nutritional support during management of refeeding-related hypophosphataemia. Protocol currently under development by management committee and will be based on review of best available evidence.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609001043224